Sánchez walks a tightrope as Spain commits to NATO target
08 May Foreign & Security Policy

Sánchez walks a tightrope as Spain commits to NATO target

With Spain pledging to spend 2% of its GDP on defence, PM Pedro Sánchez faces scepticism as he stretches the definition of military spending. Around Europe, not everyone is impressed.
by Arno Van Rensbergen
Op-ed: Europe can defend its liberal democracy if it reclaims common ground
09 May Foreign & Security Policy
Op-ed: Europe can defend its liberal democracy if it reclaims common ground
Russian gas phaseout: Why going cold turkey is easier said than done
07 May EU Institutions
Russian gas phaseout: Why going cold turkey is easier said than done
Op-ed: EU's Russian speakers are an opportunity, not a risk
07 May Culture & Arts
Op-ed: EU's Russian speakers are an opportunity, not a risk
Reform of Pharmaceutical Legislation: A Vision for a Competitive and Compassionate EU Partner Content
10 Jan
Reform of Pharmaceutical Legislation: A Vision for a Competitive and Compassionate EU
In the face of ongoing global challenges, securing the future of Europe's healthcare systems is paramount to future success
Engelbert Dollfuss: how curators dismantle a controversial museum in Austria
04 Jan Culture & Arts
Engelbert Dollfuss: how curators dismantle a controversial museum in Austria
Engelbert Dollfuss ruled Austria in the 1930s, modelling his regime on Mussolini's principles. Valeriya Safronova discovers how a controversial museum in his honour is entering its next phase
In Lithuania, national parks protect biodiversity and cultural heritage alike
02 Jan
In Lithuania, national parks protect biodiversity and cultural heritage alike
Over the 30 years since Lithuania declared independence from the Soviet Union, the country’s national parks have driven tourism, encouraged conservation and become symbolic of its sovereignty
Migration top of the agenda as Belgium outlines priorities for its Council of the EU presidency
15 Dec EU Institutions
Migration top of the agenda as Belgium outlines priorities for its Council of the EU presidency
Iceland’s Christmas book flood
15 Dec Culture & Arts
Iceland’s Christmas book flood
Jólabókaflóð is a much-loved festive tradition and the backbone of Iceland’s publishing sector
Signature dish: Markus Ferber's snowflake biscuits
14 Dec Culture & Arts
Signature dish: Markus Ferber's snowflake biscuits
German MEP Markus Ferber shares his favourite recipe for the Christmas season
Medicines in Europe: We must address affordability and availability
13 Dec
Medicines in Europe: We must address affordability and availability
The EU market for medicines remains fragmented. Member States don't have the same access to sometimes life-saving medicines. This model is not sustainable, argues MEP Alex Agius Saliba.
Biomethane’s boundless potential to decarbonise heavy-duty transport in the EU market Partner Content
12 Dec
Biomethane’s boundless potential to decarbonise heavy-duty transport in the EU market
The European Commission’s has ambitious plans to reduce Heavy Duty Vehicle (HDV) emissions by 90% by 2040, but how can the industry get there?
The art of wellbeing: How Europe is using culture for its health benefits
12 Dec Culture & Arts
The art of wellbeing: How Europe is using culture for its health benefits
Programmes using art for its health benefits are popping up all over Europe. The trend even has the support of the European institutions and the World Health Organisation
Bitter pills: Europe struggles with medicine shortages
11 Dec EU Institutions
Bitter pills: Europe struggles with medicine shortages
A fragile supply chain and increased demand are causing a shortfall in the EU’s stock of critical medicines. Gabriela Galindo looks at how policymakers can stabilise the situation
In conversation with the Alexion team working to help rare diseases patients Partner Content
11 Dec
In conversation with the Alexion team working to help rare diseases patients
At the World Orphan Drug Congress 2023, we caught up with some of the Alexion – AstraZeneca Rare Disease team to hear more about rare diseases and how the EU can best support patients.
Antimicrobial resistance is the next global health challenge
08 Dec
Antimicrobial resistance is the next global health challenge
“The sooner we act, the more damage we can prevent in the future”, says MEP Nicu Stefanuta
On the ground in Moldova: how the country fights tuberculosis
07 Dec EU Institutions
On the ground in Moldova: how the country fights tuberculosis
The country continues to grapple with high tuberculosis rates, but joining the EU could help fight the disease, reports Julia Kaiser from Moldova, where she travelled with The Global Fund
Changing perspectives and alternative thinking critical to advancing discussions around animal testing replacements Partner Content
06 Dec
Changing perspectives and alternative thinking critical to advancing discussions around animal testing replacements
MEP Jutta Paulus reflects on the barriers to implement new technologies to replace animal testing at PrecisionTox's Informative Breakfast on research and policy insights exploring the barriers to New Approach Methodologies (NAMs) for chemical risk assessment at the European Parliament
No health without brain health Partner Content
06 Dec EU Institutions
No health without brain health
Whilst an estimated 179 million Europeans live with brain conditions, brain disorders still lack the awareness and recognition in the EU
Air pollution in Europe: The silent killer
06 Dec Energy & Environment
Air pollution in Europe: The silent killer
While pollution kills thousands of Europeans each year, the European Union is failing to meet the air quality targets set by the World Health Organisation, Marilyn Wright reports
Towards a healthier Europe with medical technology Partner Content
06 Dec
Towards a healthier Europe with medical technology
How the next generation of EU policymakers can
empower patients and inspire innovation
Fostering brain research and innovation in the EU Partner Content
06 Dec
Fostering brain research and innovation in the EU
Now is the time for the EU to prioritise research and innovation into brain diseases
Boosting innovation in Europe to deliver faster patient access to treatments Partner Content
06 Dec
Boosting innovation in Europe to deliver faster patient access to treatments
With an ageing population and rising demand, ensuring fair access to new medicines and treatments is high on the political agenda. The Parliament sat down with Ilya Yuffa, Executive Vice President, and President, Lilly International, to learn more about why innovation is key to delivering better health outcomes for European citizens.
A patient driven definition of Unmet Medical Need in migraine Partner Content
05 Dec
A patient driven definition of Unmet Medical Need in migraine
Elena Ruiz de la Torre, Executive Director of the European Migraine Headache Alliance (EMHA) spoke to Ingrid Mcgowan, Head of International Patient Advocacy at AbbVie to discuss a patient driven definition of Unmet Medical Need in migraine.
Mental health in Europe: it is time for a strategy
05 Dec EU Institutions
Mental health in Europe: it is time for a strategy
In June, the Commission launched a Mental Health Communication. While this step is an admirable advancement, there is room for improvement, argues Dr. Alessandro Gallina from the European Public Health Alliance
Migraine’s in Europe and their adverse prevalence in women Partner Content
05 Dec EU Institutions
Migraine’s in Europe and their adverse prevalence in women
A European Migraine Action Plan is needed to tackle an underestimated medical condition impacting 1 in 7 people globally.
Hi-tech health: How AI is revolutionising healthcare
04 Dec Technology
Hi-tech health: How AI is revolutionising healthcare
From faster diagnosis to new drug development, AI is driving exciting breakthroughs in medical services. But there are also calls for caution. Sarah Schug reports
Self-Care can contribute to finding solutions to AMR Partner Content
04 Dec
Self-Care can contribute to finding solutions to AMR
Making antimicrobial medicines for minor infections prescription-only could undermine the health and wellbeing of European citizens